{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T12:28:23Z","timestamp":1772368103099,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:00:00Z","timestamp":1592611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:00:00Z","timestamp":1592611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81200619"],"award-info":[{"award-number":["81200619"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s42000-020-00219-5","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:02:30Z","timestamp":1592611350000},"page":"439-445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of sex hormone-binding globulin on predicting metabolic syndrome in newly diagnosed and untreated patients with polycystic ovary syndrome"],"prefix":"10.1007","volume":"19","author":[{"given":"Chen","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Minjie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Weichun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Huihuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Guishan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huang","family":"Qingxia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Xiaoping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Ping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Chujia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5006-3486","authenticated-orcid":false,"given":"Yin","family":"Guoshu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,20]]},"reference":[{"key":"219_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF (2018) Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 14:270\u2013284","journal-title":"Nat Rev Endocrinol"},{"key":"219_CR2","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/humupd\/dmy022","volume":"24","author":"MA Skiba","year":"2018","unstructured":"Skiba MA, Islam RM, Bell RJ, Davis SR (2018) Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 24:694\u2013709","journal-title":"Hum Reprod Update"},{"key":"219_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.fertnstert.2007.03.081","volume":"89","author":"EM Soares","year":"2008","unstructured":"Soares EM, Azevedo GD, Gadelha RG, Lemos TM, Maranh\u00e3o TM (2008) Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome. Fertil Steril 89:649\u2013655","journal-title":"Fertil Steril"},{"key":"219_CR4","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/cen.12830","volume":"83","author":"S Ranasinha","year":"2015","unstructured":"Ranasinha S, Joham AE, Norman RJ, Shaw JE, Zoungas S, Boyle J et al (2015) The association between polycystic ovary syndrome (PCOS) and metabolic syndrome: a statistical modelling approach. Clin Endocrinol 83:879\u2013887","journal-title":"Clin Endocrinol"},{"key":"219_CR5","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1093\/humrep\/den263","volume":"23","author":"AJ Cussons","year":"2008","unstructured":"Cussons AJ, Watts GF, Burke V, Shaw JE, Zimmet PZ, Stuckey BG (2008) Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Hum Reprod 23:2352\u20132358","journal-title":"Hum Reprod"},{"key":"219_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/cen.12086","volume":"78","author":"IR Wallace","year":"2013","unstructured":"Wallace IR, McKinley MC, Bell PM, Hunter SJ (2013) Sex hormone binding globulin and insulin resistance. Clin Endocrinol 78:321\u2013329","journal-title":"Clin Endocrinol"},{"key":"219_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1467-789X.2012.01053.x","volume":"14","author":"SS Lim","year":"2013","unstructured":"Lim SS, Norman RJ, Davies MJ, Moran LJ (2013) The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev 14:95\u2013109","journal-title":"Obes Rev"},{"key":"219_CR8","doi-asserted-by":"crossref","unstructured":"(2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157\u2013163","DOI":"10.1016\/S0140-6736(03)15268-3"},{"key":"219_CR9","doi-asserted-by":"publisher","first-page":"9376179","DOI":"10.1155\/2018\/9376179","volume":"2018","author":"K Wang","year":"2018","unstructured":"Wang K, Yang QF, Chen XL, Liu YW, Shan SS, Zheng HB et al (2018) Metabolic syndrome and its components predict the risk of type 2 diabetes mellitus in the mainland Chinese: a 3-year cohort study. Int J Endocrinol 2018:9376179","journal-title":"Int J Endocrinol"},{"key":"219_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1210\/jc.2005-1329","volume":"91","author":"DA Ehrmann","year":"2006","unstructured":"Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN (2006) Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 91:48\u201353","journal-title":"J Clin Endocrinol Metab"},{"key":"219_CR11","doi-asserted-by":"publisher","first-page":"138.e1","DOI":"10.1016\/j.ajog.2019.03.011","volume":"221","author":"Y He","year":"2019","unstructured":"He Y, Lu Y, Zhu Q, Wang Y, Lindheim SR, Qi J et al (2019) Influence of metabolic syndrome on female fertility and in vitro fertilization outcomes in PCOS women. Am J Obstet Gynecol 221:138.e1\u2013138.e12","journal-title":"Am J Obstet Gynecol"},{"key":"219_CR12","doi-asserted-by":"crossref","unstructured":"Zhu JL, Chen Z, Feng WJ, Long SL, Mo ZC (2019) Sex hormone-binding globulin and polycystic ovary syndrome. Clin Chim Acta","DOI":"10.1016\/j.cca.2019.09.010"},{"key":"219_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1210\/jcem-67-3-460","volume":"67","author":"SR Plymate","year":"1988","unstructured":"Plymate SR, Matej LA, Jones RE, Friedl KE (1988) Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 67:460\u2013464","journal-title":"J Clin Endocrinol Metab"},{"key":"219_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/MED.0b013e3283398ee2","volume":"17","author":"CA Allan","year":"2010","unstructured":"Allan CA, McLachlan RI (2010) Androgens and obesity. Curr Opin Endocrinol Diabetes Obes 17:224\u2013232","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"219_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/09513590.2017.1393062","volume":"34","author":"S Patlolla","year":"2018","unstructured":"Patlolla S, Vaikkakara S, Sachan A, Venkatanarasu A, Bachimanchi B, Bitla A et al (2018) Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance. Gynecol Endocrinol 34:238\u2013242","journal-title":"Gynecol Endocrinol"},{"key":"219_CR16","doi-asserted-by":"publisher","first-page":"e0205592","DOI":"10.1371\/journal.pone.0205592","volume":"13","author":"S Xargay-Torrent","year":"2018","unstructured":"Xargay-Torrent S, Carreras-Badosa G, Borrat-Padrosa S, Prats-Puig A, Soriano P, \u00c1lvarez-Casta\u00f1o E et al (2018) Circulating sex hormone binding globulin: an integrating biomarker for an adverse cardio-metabolic profile in obese pregnant women. PLoS One 13:e0205592","journal-title":"PLoS One"},{"key":"219_CR17","first-page":"197","volume":"64","author":"Y Hong","year":"2013","unstructured":"Hong Y, Chen D, Li Y, Li C, Liu Y, Xie M (2013) Serum sex hormone binding globulin profile and its association with insulin resistance in Chinese peri-menopausal women. Endokrynol Pol 64:197\u2013201","journal-title":"Endokrynol Pol"},{"key":"219_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/GME.0000000000001250","volume":"26","author":"C Duggan","year":"2019","unstructured":"Duggan C, Tapsoba JD, Stanczyk F, Wang CY, Schubert KF, McTiernan A (2019) Long-term weight loss maintenance, sex steroid hormones, and sex hormone-binding globulin. Menopause 26:417\u2013422","journal-title":"Menopause"},{"key":"219_CR19","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/humrep\/det057","volume":"28","author":"JJ Kim","year":"2013","unstructured":"Kim JJ, Chae SJ, Choi YM, Hwang KR, Song SH, Yoon SH et al (2013) Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome. Hum Reprod 28:1354\u20131360","journal-title":"Hum Reprod"},{"key":"219_CR20","doi-asserted-by":"publisher","first-page":"1473612","DOI":"10.1155\/2016\/1473612","volume":"2016","author":"L Pkhaladze","year":"2016","unstructured":"Pkhaladze L, Barbakadze L, Kvashilava N (2016) Myo-inositol in the treatment of teenagers affected by PCOS. Int J Endocrinol 2016:1473612","journal-title":"Int J Endocrinol"},{"key":"219_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1210\/jc.2004-1376","volume":"90","author":"V Sepilian","year":"2005","unstructured":"Sepilian V, Nagamani M (2005) Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance. J Clin Endocrinol Metab 90:60\u201365","journal-title":"J Clin Endocrinol Metab"},{"key":"219_CR22","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1093\/humrep\/dei104","volume":"20","author":"IA Penna","year":"2005","unstructured":"Penna IA, Canella PR, Reis RM, de S\u00e1 MFS, Ferriani RA (2005) Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study. Hum Reprod 20:2396\u20132401","journal-title":"Hum Reprod"},{"key":"219_CR23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/humrep\/deh588","volume":"20","author":"D Cibula","year":"2005","unstructured":"Cibula D, Fanta M, Vrbikova J, Stanicka S, Dvorakova K, Hill M et al (2005) The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients. Hum Reprod 20:180\u2013184","journal-title":"Hum Reprod"},{"key":"219_CR24","first-page":"8196","volume":"29","author":"A Alinezhad","year":"2019","unstructured":"Alinezhad A, Jafari F (2019) The relationship between components of metabolic syndrome and plasma level of sex hormone-binding globulin. Eur J Transl Myol 29:8196","journal-title":"Eur J Transl Myol"},{"key":"219_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2217\/bmm-2016-0030","volume":"12","author":"T Zhang","year":"2018","unstructured":"Zhang T, Du T, Li W, Yang S, Liang W (2018) Sex hormone-binding globulin levels during the first trimester may predict gestational diabetes mellitus development. Biomark Med 12:239\u2013244","journal-title":"Biomark Med"},{"key":"219_CR26","doi-asserted-by":"publisher","first-page":"e1002542","DOI":"10.1371\/journal.pmed.1002542","volume":"15","author":"B Kumarendran","year":"2018","unstructured":"Kumarendran B, O'Reilly MW, Manolopoulos KN, Toulis KA, Gokhale KM, Sitch AJ et al (2018) Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database. PLoS Med 15:e1002542","journal-title":"PLoS Med"},{"key":"219_CR27","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1210\/jc.2002-020557","volume":"88","author":"V Jayagopal","year":"2003","unstructured":"Jayagopal V, Kilpatrick ES, Jennings PE, Hepburn DA, Atkin SL (2003) The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance. J Clin Endocrinol Metab 88:1528\u20131533","journal-title":"J Clin Endocrinol Metab"},{"key":"219_CR28","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.fertnstert.2006.02.108","volume":"86","author":"MH Dahan","year":"2006","unstructured":"Dahan MH, Goldstein J (2006) Serum sex hormone-binding globulin levels show too much variability to be used effectively as a screening marker for insulin resistance in women with polycystic ovary syndrome. Fertil Steril 86:934\u2013941","journal-title":"Fertil Steril"},{"key":"219_CR29","doi-asserted-by":"crossref","unstructured":"(2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41\u201347","DOI":"10.1093\/humrep\/deh098"},{"key":"219_CR30","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R et al (2013) Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 98:4565\u20134592","journal-title":"J Clin Endocrinol Metab"},{"key":"219_CR31","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W et al (2009) The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456\u2013488","journal-title":"Fertil Steril"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-020-00219-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-020-00219-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-020-00219-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T23:23:03Z","timestamp":1624144983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-020-00219-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,20]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["219"],"URL":"https:\/\/doi.org\/10.1007\/s42000-020-00219-5","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,20]]},"assertion":[{"value":"17 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was granted by the Ethics Committee of the First Affiliated Hospital of Shantou University Medical College.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}